Evidence map›Paper›PMID 25511480›Full record

Trial reportJournal of clinical pharmacology2015

The evaluation of thioridazine as a hematopoietic progenitor cell mobilizing agent in healthy human subjects.

Alexandre Chigaev, Larry A Sklar, Ronald Schrader, Nicole Stephens, Hengameh Raissy, Stuart S Winter

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of clinical pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. New agents in HSC mobilization.International journal of hematology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alexandre ChigaevUniversity of New Mexico Center for Molecular Discovery, University of New Mexico, Albuquerque, NM, USA.
Larry A Sklar
Ronald Schrader
Nicole Stephens
Hengameh Raissy
Stuart S Winter

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
Force, Conformation & Affinity in VLA-4 and LFA-1 AdhesionR01HL081062 · NHLBI · UNIVERSITY OF NEW MEXICO · PI SKLAR, LARRY A. · 2007 to 2011
$2.4M
NCATS NIH HHS UL1 TR000041NCATS NIH HHS UL1 TR00041NCATS NIH HHS UL1 TR001449NCI NIH HHS 2P30 CA118100-14NCI NIH HHS P30 CA118100NHLBI NIH HHS R01 HL081062
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntigens, CD34Cell AdhesionDose-Response Relationship, DrugFemaleHematopoietic Stem Cell MobilizationHumansIntegrin alpha4beta1MaleThioridazineAntigens, CD34Integrin alpha4beta1ThioridazineCD34+ hematopoietic progenitor cellsstem cell transplantationthioridazineVLA-4

Identifiers

PMID25511480
PMCPMC4420020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.